Global Zika Virus Testing Market Growth (Status and Outlook) 2023-2029

Global Zika Virus Testing Market Growth (Status and Outlook) 2023-2029

Zika Virus Testing is a test tools for Zika virus, including the Nucleic Acid Amplification Test/ Molecular Tests; Zika Virus Antibody Test/ Serological Test. Zika virus (Zika) is a disease caused by the Zika virus, which is spread to people primarily through the bite of an infected Aedes species mosquito. The most common symptoms of Zika are fever, rash, joint pain, and conjunctivitis. The illness is usually mild with symptoms lasting for several days to a week after being bitten by an infected mosquito. People usually don’t get sick enough to go to the hospital, and they very rarely die of Zika. For this reason, many people might not realize they have been infected. However, Zika virus infection during pregnancy can cause a serious birth defect called microcephaly, as well as other severe fetal brain defects. Once a person has been infected, he or she is likely to be protected from future infections. Zika virus testing is recommended only for certain people. People live in or traveled to an area with risk of Zika; People had sex without a condom with a partner who lives in or traveled to an area with risk of Zika; Pregnant women who don’t have Zika symptoms lives in or traveled to an area with risk of Zika.
LPI (LP Information)' newest research report, the “Zika Virus Testing Industry Forecast” looks at past sales and reviews total world Zika Virus Testing sales in 2022, providing a comprehensive analysis by region and market sector of projected Zika Virus Testing sales for 2023 through 2029. With Zika Virus Testing sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Zika Virus Testing industry.
This Insight Report provides a comprehensive analysis of the global Zika Virus Testing landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Zika Virus Testing portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Zika Virus Testing market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Zika Virus Testing and breaks down the forecast by type, by application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Zika Virus Testing.
The global Zika Virus Testing market size is projected to grow from US$ 113.5 million in 2022 to US$ 141.6 million in 2029; it is expected to grow at a CAGR of 3.2% from 2023 to 2029.
Global Zika Virus Testing key players include Chembio, Quest Diagnostics, ARUP Laboratories, Luminex Corporation, Simens, etc. Global top five manufacturers hold a share about 55%. North America is the largest market, with a share about 45%, followed by Europe, with a share about 30 percent. In terms of product, Molecular Test is the largest segment, with a share about 90%. And in terms of application, the largest application is Diagnostic Centers, followed by Hospitals, Pathology Labs, etc.
This report presents a comprehensive overview, market shares, and growth opportunities of Zika Virus Testing market by product type, application, key players and key regions and countries.
Market Segmentation:
Segmentation by type
Molecular Test
Serologic Test
Segmentation by application
Diagnostic Centers
Hospitals
Pathology Labs
This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.
Chembio
Quest Diagnostics
ARUP Laboratories
Luminex
Simens
Abbott Molecular
Hologic
ELITech Molecular Diagnostics
EUROIMMUN US
Creative Diagnostics
Vela Diagnostics
InBios International
Primerdesign
Altona Diagnostics

Please note: The report will take approximately 2 business days to prepare and deliver.